Background
MW Gestion, a Sinovac Biotech Ltd. shareholder, brought a putative class action against 1Globe Capital LLC, Jiaqiang Li, and related defendants. It alleged that the defendants concealed the extent of their Sinovac shareholdings to evade federal disclosure requirements and delay activation of a shareholder-rights plan containing a poison-pill provision. MW Gestion asserted securities-fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and a claim for tortious interference with the rights agreement.
The district court dismissed the securities claims as untimely but initially allowed the contract-interference claim to proceed. The case was stayed while courts in Antigua considered the rights agreement’s validity. After the Judicial Committee of the Privy Council held the agreement invalid in January 2025, MW Gestion sought to add a claim for tortious interference with business relations. The district court denied leave to amend for undue delay, and the parties dismissed the remaining contract claim with prejudice while preserving MW Gestion’s appellate rights.
The Court’s Holding
The First Circuit affirmed the denial of leave to amend. The court held that the district court reasonably found MW Gestion had taken an impermissible “wait and see” approach. Because the validity of the rights agreement had been contested throughout the Antigua litigation, MW Gestion knew from the outset that an adverse ruling could defeat its contract-based claim. It nevertheless waited more than two years and until after the Privy Council’s decision to pursue an alternative business-relations theory based on the same underlying facts.
The court also affirmed dismissal of the securities-fraud claims under the two-year discovery limitation in 28 U.S.C. § 1658(b)(1). A May 2020 SEC cease-and-desist order detailed the alleged misconduct, and MW Gestion’s amended complaint relied extensively on that order. Because MW Gestion did not sue until August 16, 2022, its claims were untimely. The continuing suspension of Sinovac stock trading did not postpone accrual, and the pending foreign litigation did not constitute an exceptional circumstance warranting equitable tolling.
Key Takeaways
- A plaintiff may unduly delay amendment by withholding an available alternative theory while awaiting the outcome of related litigation.
- The securities-fraud limitations period began no later than the SEC order that disclosed the alleged misconduct on which the complaint relied.
- Unresolved litigation and a continuing trading suspension did not prevent MW Gestion from pleading its claims or justify equitable tolling.
Why It Matters
The decision underscores that Rule 15’s liberal amendment standard does not protect strategic delay. When a claim depends on an issue being litigated elsewhere, counsel should consider pleading viable alternative theories before that issue is finally resolved.
It also illustrates how a public enforcement order can trigger the Exchange Act’s discovery-based limitations period when the order reveals the facts later used to support a private securities-fraud complaint.